<DOC>
	<DOCNO>NCT02985320</DOCNO>
	<brief_summary>The purpose study evaluate safety sIPVs different dosage adult , child infant phase I open-label study , assess immunogenicity safety healthy infant 60 90 day old phase II blind , randomize , control study .</brief_summary>
	<brief_title>Studies Safety Immunogenicity Sabin Inactivated Poliovirus Vaccine</brief_title>
	<detailed_description>This study combination phase I II . Phase I study open-label , collect safety information investigational sIPVs adult , child infant . Phase II study double-blind , randomize , control study immunogenicity safety investigational vaccine two commercialize inactivated poliovirus vaccine healthy infant .</detailed_description>
	<mesh_term>Poliomyelitis</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy volunteer 6090 day old , 612 year old , 1849 year old ; Healthy volunteer fulfill require condition receive investigational vaccine establish medical history clinical examination determine investigator ; Proven legal identity ; Participants ( ≥ 18 year old ) , guardians participant ( &lt; 18 year old ) capable understand write consent form , form sign prior enrolment ; Complying requirement study protocol ; Axillary temperature ≤ 37.0 °C ; Breast feeding , pregnant , expect conceive next 60 day ; History allergy vaccine , ingredient vaccine , serious adverse reaction ( ) vaccination , urticaria , dyspnea , angioneurotic edema , abdominal pain , etc ; Congenital malformation , developmental disorder , genetic defect , severe malnutrition ; Autoimmune disease immunodeficiency/immunosuppressive ; serious chronic disease , serious cardiovascular disease , hypertension diabetes stabilize medication , liver kidney disease , malignancy , etc ; severe nervous system disease ( epilepsy , seizure convulsion ) mental illness ; History thyroidectomy , asplenia , functional asplenia , condition result absence removal spleen ; Bleeding disorder diagnose doctor ( e.g. , coagulation factor deficiency , coagulation disorder , platelet disorder ) , significant bruising coagulopathy ; Long term history alcoholism drug abuse ; Receipt follow product : 1 . Any subunit inactivated vaccine within past 7 day ; 2 . Any live attenuate vaccine within past 14 day ; 3 . Any investigational medicine ( ) within past 30 day ; 4 . Any blood product within past 3 month ; 5 . Any immunosuppressant , cytotoxic medication , inhaled corticosteroid ( except corticosteroid spray treatment allergic rhinitis corticosteroid treatment surface acute noncomplicated dermatitis ) within past 6 month prior study entry ; Acute illness acute exacerbation chronic disease within past 7 day ; Axillary temperature &gt; 37.0 °C ; Infant participant prior vaccination poliovirus ; Any factor , judgment investigator , suggest volunteer unsuitable study ;</criteria>
	<gender>All</gender>
	<minimum_age>2 Months</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Sabin strain</keyword>
	<keyword>Inactivated poliovirus vaccine</keyword>
	<keyword>poliomyelitis</keyword>
	<keyword>safety</keyword>
	<keyword>immunogenicity</keyword>
	<keyword>infant</keyword>
</DOC>